Seven Internationally Recognized Scientists have Recently Joined the Company’s Scientific Advisory Board
Prof. Raphael Mechoulam
A Professor Emeritus of the School of Pharmacy at the Faculty of Medicine of the Hebrew University in Jerusalem, he is a recipient of the Israel Prize, known for his work in identifying the main active compound in the cannabis plant, THC, and is a world-renowned expert in pharmaceutical cannabinoid research.
Prof. James Leckman
A child psychiatrist, psychiatrist and physician at Yale University, served as Director of the Child Study Center at Yale for over two decades and is a prominent international expert in the field of research and treatment of Tourette Syndrome.
Dr. Michael Bloch
Chief Resident at Yale’s Clinical Neuroscience Research Unit, noted researcher on the study of Tourette Syndrome, obsessive-compulsive disorder and trichotillomania.
Prof. Daniele Piomelli
The Editor-in-Chief of Cannabis and Cannabinoid Research, Prof. Piomelli serves as Louise Turner Arnold Chair in Neurosciences and Professor of Anatomy and Neurobiology, Pharmacology, and Biological Chemistry at University of California, Irvine.
Prof. Michael Davidson
Professor of Psychiatry, served as Chief Psychiatrist at the Department of Psychiatry of the Sheba Medical Centre Tel-Hashomer, and currently serves as Chairman of the Stuckinski Centre for Alzheimer’s Disease Research in Ramat Gan, Israel.
Prof. Avi Weizman
Professor of Psychiatry at the Sackler School of Medicine Tel Aviv University, Head of the Laboratory of Biological Psychiatry at the Felsentein Medical Research Center and Director and Head of Geha Mental Health Center’s Research Unit.
Prof. Kirsten Müller-Vahl
Professor of Psychiatry the Hannover Medical School, Germany, recognized as the leading researcher in the field of cannabinoid use in treatment of Tourette Syndrome and since 1994 has served as a member of the scientific advisory board of the German Tourette Syndrome Association.